Cardio Diagnostics Holdings, Inc. Amortization
Cardio Diagnostics Holdings, Inc. (CDIO) reported Amortization of $101.57 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. amortization for the quarter ending 2026-06-30 was $51.16K, a 0.39% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. amortization for the quarter ending 2026-03-31 was $50.41K, a 42.49% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. amortization for the quarter ending 2025-12-31 was $49.86K, a 6.22% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. amortization for the quarter ending 2025-09-30 was $49.19K, a 7.50% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. amortization for fiscal 2025 was $238.06K, a 46.44% increase from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. amortization for fiscal 2024 was $162.57K, a 50.76% increase from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. amortization for fiscal 2023 was $107.83K, a 573.94% increase from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. amortization for fiscal 2022 was $16.00K, a 0.00% change from fiscal 2021.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $51.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $101.57K 10-Q · filed 2026-08-07 | $151.43K derived: sum of 3 quarters · filed 2026-08-07 | $200.61K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $50.41K 10-Q · filed 2026-05-15 | $100.27K derived: sum of 2 quarters · filed 2026-05-15 | $149.46K derived: sum of 3 quarters · filed 2026-05-15 | $200.81K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $49.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $99.04K derived: sum of 2 quarters · filed 2026-03-13 | $150.40K derived: sum of 3 quarters · filed 2026-08-07 | $238.06K 10-K · filed 2026-03-13 |
| 2025-09-30 | $49.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $100.54K derived: sum of 2 quarters · filed 2026-08-07 | $188.21K 10-Q · filed 2025-11-12 | $235.14K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $51.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $139.02K 10-Q · filed 2026-08-07 | $185.96K derived: sum of 3 quarters · filed 2026-08-07 | $231.71K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $87.66K 10-Q · filed 2026-05-15 | $134.60K derived: sum of 2 quarters · filed 2026-05-15 | $180.35K derived: sum of 3 quarters · filed 2026-05-15 | $225.48K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $46.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $92.69K derived: sum of 2 quarters · filed 2026-03-13 | $137.82K derived: sum of 3 quarters · filed 2026-03-13 | $162.57K 10-K · filed 2026-03-13 |
| 2024-09-30 | $45.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $90.88K derived: sum of 2 quarters · filed 2025-11-12 | $115.63K 10-Q · filed 2025-11-12 | $175.04K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $45.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $69.88K 10-Q · filed 2025-08-14 | $129.28K derived: sum of 3 quarters · filed 2025-08-14 | $168.13K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $24.75K 10-Q · filed 2025-05-15 | $84.15K derived: sum of 2 quarters · filed 2025-05-15 | $123.00K derived: sum of 3 quarters · filed 2025-05-15 | $127.80K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $59.40K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $98.25K derived: sum of 2 quarters · filed 2025-03-20 | $103.05K derived: sum of 3 quarters · filed 2025-03-20 | $107.83K 10-K · filed 2025-03-20 |
| 2023-09-30 | $38.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $43.64K derived: sum of 2 quarters · filed 2024-11-13 | $48.43K 10-Q · filed 2024-11-13 | $52.43K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $4.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $9.58K 10-Q · filed 2024-08-12 | $13.58K derived: sum of 3 quarters · filed 2024-08-12 | $17.58K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $4.79K 10-Q · filed 2024-05-15 | $8.79K derived: sum of 2 quarters · filed 2024-05-15 | $12.79K derived: sum of 3 quarters · filed 2024-05-15 | $16.79K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $8.00K derived: sum of 2 quarters · filed 2024-04-01 | $12.00K derived: sum of 3 quarters · filed 2024-04-01 | $16.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $8.00K derived: sum of 2 quarters · filed 2023-11-13 | $12.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $8.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $16.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |